Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-04-23

FDA Approved: FELBAMATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for felbamate (Felbatol) filed by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Felbatol (felbamate)

Snippet

SUPPL AP for FELBAMATE (FELBAMATE)